Who is sponsoring NCT03680547?

NCT03680547 is sponsored by Assiut University.

What drugs are being tested in NCT03680547?

Interventions in NCT03680547: patient with sickle cell disease.

What condition does NCT03680547 study?

NCT03680547 studies Sickle Cell Nephropathy.

Is NCT03680547 still recruiting?

NCT03680547 is currently status unknown. Last updated 29 November 2019.

Last reviewed 2019-11-29 · How we verify

NCT03680547

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nephropathy in Patients With Sickle Cell Disease

Status unknown Last updated 29 November 2019

What this trial tests

trial testing patient with sickle cell disease in Sickle Cell Nephropathy in 25 participants. Status unknown.

Timeline

1 May 2020

Primary endpoint
30 May 2020

1 January 2021

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	25
Start date	1 May 2020
Primary completion	30 May 2020
Estimated completion	1 January 2021

Drugs / interventions tested

patient with sickle cell disease

Conditions studied

Sickle Cell Nephropathy — all drugs for Sickle Cell Nephropathy →

Sponsor

Assiut University

Who can join

Adults 5 Months to 18, any sex, with Sickle Cell Nephropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There are some diseases that give rise to diverse renal manifestations as does sickle cell disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sickle Cell Nephropathy

Currently open trials in the same condition.

NCT06065852 — National Registry of Rare Kidney Diseases · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03680547 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 29 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03680547.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing